Treatment of Herpes simplex encephalitis with the helicase-primase inhibitor pritelivir in an immunocompromised patient.

Lueck C, Rautenberg C, Birkmann A, Bonsmann S, Marini A, Sumner M, Schroeder T, Voigt S

DOI: 10.1038/s44259-026-00262-z
Published: 2026 Sep 2
Container: npj antimicrobials and resistance
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s44259-026-00262-z,
  title = {Treatment of Herpes simplex encephalitis with the helicase-primase inhibitor pritelivir in an immunocompromised patient.},
  author = {Lueck C and Rautenberg C and Birkmann A and Bonsmann S and Marini A and Sumner M and Schroeder T and Voigt S},
  year = {2026},
  journal = {npj antimicrobials and resistance},
  doi = {10.1038/s44259-026-00262-z},
  url = {https://doi.org/10.1038/s44259-026-00262-z}
}

RIS

TY  - JOUR
TI  - Treatment of Herpes simplex encephalitis with the helicase-primase inhibitor pritelivir in an immunocompromised patient.
AU  - Lueck C
AU  - Rautenberg C
AU  - Birkmann A
AU  - Bonsmann S
AU  - Marini A
AU  - Sumner M
AU  - Schroeder T
AU  - Voigt S
PY  - 2026
JO  - npj antimicrobials and resistance
DO  - 10.1038/s44259-026-00262-z
UR  - https://doi.org/10.1038/s44259-026-00262-z
ER  -

APA

C, L., C, R., A, B., S, B., A, M., M, S., T, S., & S, V. (2026). Treatment of Herpes simplex encephalitis with the helicase-primase inhibitor pritelivir in an immunocompromised patient.. npj antimicrobials and resistance. https://doi.org/10.1038/s44259-026-00262-z

Source records

pubmed · retrieved 2026-09-27T07:07:12.963Z